Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25927225 | 1.00 | CHEK2 (0.31) | CHEK2MMP12 | |
| SCHEMBL25927909 | 1.00 | CHEK2 (0.31) | CHEK2MMP12 | |
| SCHEMBL25927343 | 1.00 | CHEK2 (0.31) | CHEK2MMP12 | |
| SCHEMBL25927234 | 0.97 | CHEK2 (0.32) | CHEK2MMP12 | |
| SCHEMBL25927349 | 0.97 | CHEK2 (0.32) | CHEK2MMP12 | |
| SCHEMBL25927920 | 0.97 | CHEK2 (0.32) | CHEK2MMP12 | |
| SCHEMBL25928057 | 0.97 | KDM4E (0.31) | CHEK2 | |
| SCHEMBL25927350 | 0.97 | KDM4E (0.31) | CHEK2 | |
| SCHEMBL24232472 | 0.97 | CHEK2 (0.32) | CHEK2MMP12 | |
| SCHEMBL25927922 | 0.97 | CHEK2 (0.32) | CHEK2MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | CHEK2 1593/4885MMP12 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.